Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-17-00069R1_FINAL_Reix_16072017.pdf
[2] https://www.ncbi.nlm.nih.gov/pubmed/?term=Real-life%20acute%20lung%20function%20changes%20after%20lumacaftor/ivacaftor%20first%20administration%20in%20pediatric%20patients%20with%20cystic%20fibrosis
[3] https://www.ecfs.eu/research-article-keywords/acute
[4] https://www.ecfs.eu/research-article-keywords/airway-obstruction
[5] https://www.ecfs.eu/research-article-keywords/bronchoconstriction
[6] https://www.ecfs.eu/research-article-keywords/lumacaftor
[7] https://www.ecfs.eu/research-article-keywords/modulators
[8] https://www.ecfs.eu/research-article-keywords/pediatric
[9] https://www.ecfs.eu/resource-guideline-type/other-guidelines